Relief Therapeutics Holding AG logo

Relief Therapeutics Holding AG

SIX:RLF.SW

Overview | Financials
Company Name Relief Therapeutics Holding AG
Symbol RLF.SW
Currency CHF
Price 1.11
Market Cap 14,295,572
Dividend Yield 0%
52-week-range 1.1 - 4.885
Industry Biotechnology
Sector Healthcare
CEO Mr. Jack Weinstein M.B.A.
Website https://www.relieftherapeutics.com

An error occurred while fetching data.

About Relief Therapeutics Holding AG

Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or

Related Stocks

SHL Telemedicine Ltd. logo

SHL Telemedicine Ltd.

SHLTN.SW

8.9 CHF

Molecular Partners AG logo

Molecular Partners AG

MOLN.SW

9 CHF

IVF Hartmann Holding AG logo

IVF Hartmann Holding AG

VBSN.SW

129 CHF

Ascom Holding AG logo

Ascom Holding AG

ASCN.SW

7.69 CHF

Evolva Holding SA logo

Evolva Holding SA

EVE.SW

0.97 CHF

Basilea Pharmaceutica AG logo

Basilea Pharmaceutica AG

BSLN.SW

40.55 CHF

Kuros Biosciences AG logo

Kuros Biosciences AG

KURN.SW

11.4 CHF

Newron Pharmaceuticals S.p.A. logo

Newron Pharmaceuticals S.p.A.

NWRN.SW

10.72 CHF

Financials

Numbers are in millions USD

Numbers are in millions USD